Periodic Reporting for period 2 - BlueBio4Future (BlueBio4Future – Blue Biotechnology and Bioengineering for the Current and Future Development of a Blue Bioeconomy in Portugal)
Reporting period: 2022-04-01 to 2023-09-30
Despite the constraints of COVID-19 pandemic, the project was implemented, human resources hired and research work was carried out in the areas of synthetic biology, discovery of new compounds and bioinformatics which will result in presentations at international conferences and submitted publications (featuring in the next period report), some of them already public through preprint publications. All scientific data published on those preprints is currently public, and in accordance with the FAIR principles and as described on the Data Management Plan of the BlueBio4Future project, already submitted to the EC.
1. Optimization of technology platforms, not only with new equipment, human resources but, essentially, specialized knowledge.
2. Implementation of new methodologies and forefront technologies in bioengineering.
3. It is expected to increase the quality and influential papers and books, participation in workshops, organization of discussion groups and committees
4. Submission of ERC grant proposals and Marie Skłodowska-Curie Actions (Innovative Training Networks and Individual fellowships)
Competitiveness and sustainability of European biotechnological industries
1. Submission of research proposals to HORIZON EUROPE, namely with market-driven proposals
2. Increase the attractiveness of the institution for the internationally excellent and mobile researchers
3. Improve capability to compete successfully for internationally competitive research funding
4. Increase national and international partnerships
5. Increase ocean literacy for all.
Improvement of the innovation capacity and stakeholders
1. CIIMAR should become a national example of bridging the cross-fertilization activities performed in academia and innovating industry and the marked in a long run.
2. Stakeholder collaboration and knowledge transfer between research and industry is being the key to track market trends and needs, identify opportunities for innovative technologies and products and fast-track product commercialization and the impact of the emerging biotechnological SMEs.
3. Reinforce social and economic impact of our research, including science-policy interfaces.